Dean James Dalton Named Executive Vice President and Provost at the University of Alabama
University of Michigan College of Pharmacy Dean James T. Dalton, PhD, has been named the next Executive Vice President and Provost at the University of Alabama, effective August 1. Provost Susan Collins will appoint an interim dean and outline a plan for a permanent dean search. Dean Dalton will work closely with the interim dean to ensure a smooth transition.
The Michigan Pharmacy community thanks Dean Dalton for his tremendous leadership and wishes him the best of luck in his new role.
“When I came to Michigan, it was a ‘once in a lifetime’ opportunity to work with an amazing community of campus leaders, fellow deans, faculty, staff, students, alumni, and other friends. I know that I will have lifelong friends from my time here. It has been an amazing five years in Ann Arbor and I am proud of the many achievements that we’ve accomplished,” explains Dean Dalton.
During his five years at the College, Dean Dalton oversaw the doubling of its research expenditures, launched a new master of science program, received full accreditation from the Accreditation Council for Pharmacy Education, and had a $121 million building for the College of Pharmacy approved by the Board of Regents.
In 2019, Dean Dalton was elected to the National Academy of Medicine of the National Academies, one of health and medicine’s highest honors.
Prior to joining U-M, Dean Dalton was an assistant/associate professor at the University of Tennessee (1992-2000) and professor and chair in the Division of Pharmaceutics at Ohio State (2000-2007). He left on an entrepreneurial leave of absence from Ohio State in 2005 to join the small, Memphis-based drug development company GTx Inc. as vice president of preclinical research and development and chief scientific officer to advance the clinical development of SARMs. He stayed at GTx through 2014, then joined U-M as professor and dean of the College of Pharmacy.
Dean Dalton has received many awards and honors during his career, mentoring over 20 PhD students in his UT and Ohio State labs, and twice winning the Excellence in Teaching Award. He has co-authored over 300 abstracts and is an inventor on over 400 patent applications related to SARMs, selective estrogen receptor alpha and beta ligands, tubulin antagonists, and receptor tyrosine kinase inhibitors. He is a fellow in the American Association for the Advancement of Science and the American Association of Pharmaceutical Scientists.
Dean Dalton earned a Bachelor of Science in pharmacy from the University of Cincinnati and a PhD in pharmaceutics and pharmaceutical chemistry from Ohio State. He was a staff pharmacist at Kettering Medical Center in Kettering, Ohio, and had a postdoctoral fellowship in the Division of Pharmaceutics and Pharmaceutical Chemistry at Ohio State.